Peter Brereton - Tecsys CEO and President and Director
| TCYSF Stock | USD 30.80 0.25 0.81% |
CEO
Mr. Peter Brereton is President, Chief Executive Officer, Director of Tecsys Inc. He was appointed President of TECSYS Inc. in 1995 and CEO in 1998 and was largely responsible for TECSYS IPO on the Toronto and Montreal stock exchanges. He repositioned the company into the supply chain execution market in 1998 and has led the company strategies to increase market share in the supply chain management software arena for highvolume distributed order fulfillment. In 2001 the thin delivering its Webbased supply chain management suite of applications. since 2006.
| Tenure | 19 years |
| Phone | 514 866 0001 |
| Web | https://www.tecsys.com |
Tecsys Management Efficiency
The company has return on total asset (ROA) of 0.0183 % which means that it generated a profit of $0.0183 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0637 %, meaning that it generated $0.0637 on every $100 dollars invested by stockholders. Tecsys' management efficiency ratios could be used to measure how well Tecsys manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 7 records | CEO Age | ||
| Richard Cunningham | Anebulo Pharmaceuticals | 54 | |
| Rachelle Jacques | Akari Therapeutics PLC | 53 | |
| Samir MD | Akari Therapeutics PLC | 56 | |
| Stephen Esq | NRx Pharmaceuticals | 63 | |
| Deborah MD | Armata Pharmaceuticals | 68 | |
| LLM JD | Tempest Therapeutics | 55 | |
| Milton Werner | Inhibikase Therapeutics | 61 | |
Management Performance
| Return On Equity | 0.0637 | |||
| Return On Asset | 0.0183 |
Tecsys Inc Leadership Team
Elected by the shareholders, the Tecsys' board of directors comprises two types of representatives: Tecsys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tecsys. The board's role is to monitor Tecsys' management team and ensure that shareholders' interests are well served. Tecsys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tecsys' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Brereton, CEO and President and Director | ||
| Bill King, Chief Officer | ||
| Nancy Cloutier, Chief Officer | ||
| Catalin Badea, Chief Officer | ||
| David Brereton, Executive Chairman | ||
| Martin Wulff, Managing AS | ||
| Mark Bentler, CFO Sec | ||
| Robert Colosino, VP Devel | ||
| Catherine Sigmar, Chief Initiatives | ||
| Vito Calabretta, VP Operations |
Tecsys Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Tecsys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0637 | |||
| Return On Asset | 0.0183 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 265.19 M | |||
| Shares Outstanding | 14.57 M | |||
| Shares Owned By Insiders | 19.39 % | |||
| Shares Owned By Institutions | 30.35 % | |||
| Price To Earning | 65.08 X | |||
| Price To Book | 6.50 X |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Tecsys Pink Sheet
Tecsys financial ratios help investors to determine whether Tecsys Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tecsys with respect to the benefits of owning Tecsys security.